These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 272843)

  • 1. Comparison of the mediator release from platelets and the development of acute inflammation in rats which lack prostaglandin precursors.
    Bult H; Bonta IL
    Agents Actions Suppl; 1977; 2():47-59. PubMed ID: 272843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1977; 14(6):1043-53. PubMed ID: 601247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D; De Clerck F
    Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
    Hanasaki K; Nakano T; Arita H
    Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin inhibits the formation of endoperoxide metabolites in rat platelets: aspirin-like activity.
    Hwang DH; LeBlanc P
    Prostaglandins Med; 1981 Apr; 6(4):341-4. PubMed ID: 7280114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenflumizole: interactions with the arachidonic acid cascade.
    Corell T; Hasselmann G; Splawinski J; Wojtaszek B
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):297-303. PubMed ID: 6417973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic effects of phospholipase A2 on platelet aggregation. Effect of prostaglandin synthesis inhibitors and essential fatty acid deficiency.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1976 Dec; 12(6):971-9. PubMed ID: 1005744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation by phospholipase A2 of prostaglandins and endoperoxides in platelets of normal and essential fatty acid-deficient rats.
    Vincent JE; Zijlstra FJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():143-6. PubMed ID: 655005
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E.
    Karpen CW; Merola AJ; Trewyn RW; Cornwell DG; Panganamala RV
    Prostaglandins; 1981 Oct; 22(4):651-61. PubMed ID: 6798639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.